Cytomegalovirus Survival and Transferability and the Effectiveness of Common Hand-Washing Agents against Cytomegalovirus on Live Human Hands

Applied and Environmental Microbiology

Volumn 80, Issue 2, 2014, Pages 455-461

  Stowell, Jennifer D ^a   Forlin Passoni, Daniela ^b   Radford, Kay ^b   Bate, Sheri L ^b   Dollard, Sheila C ^b   Bialek, Stephanie R ^b   Cannon, Michael J ^a   Schmid, D Scott ^b  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN HANDS; INFECTION CONTROL; INFECTIOUS PARTICLES; REAL-TIME PCR;

BACTERIA; POLYMERASE CHAIN REACTION; VIRUSES;

RECOVERY;

DISEASE TRANSMISSION; GUIDELINE; INFECTIOUS DISEASE; POLYMERASE CHAIN REACTION; PREGNANCY; REAL TIME; SAMPLING; SURVIVAL; VIRUS;

DOMESTIC CHEMICAL; SOAP;

ARTICLE; CLINICAL TRIAL; CYTOMEGALOVIRUS; DRUG EFFECT; FEMALE; FIBROBLAST; GENETICS; HAND; HAND WASHING; HUMAN; MALE; METHODOLOGY; MICROBIOLOGY; PATHOGENICITY; PHYSIOLOGY; SALIVA;

CYTOMEGALOVIRUS; FEMALE; FIBROBLASTS; HAND; HAND DISINFECTION; HOUSEHOLD PRODUCTS; HUMANS; MALE; SALIVA; SOAPS;

EID: 84892452982     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.03262-13     Document Type: Article

References (28)

1. Mocarski ES, Shenk T, Pass RF. 2007. Cytomegaloviruses, p 2702-2772. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
2. Kenneson A, Cannon MJ. 2007. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev. Med. Virol. 17:253-276. http://dx.doi.org/10.1002/rmv.535.
3. Cannon MJ, Davis KF. 2005. Washing our hands of the congenital cytomegalovirus disease epidemic. BMC Public Health 5:70. http://dx.doi.org/10.1186/1471-2458-5-70.
4. Cannon MJ, Schmid DS, Hyde TB. 2010. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev. Med. Virol. 20:202-213. http://dx.doi.org/10.1002/rmv.655.
5. Arvin AM, Fast P, Myers M, Plotkin S, Rabinovich R. 2004. Vaccine development to prevent cytomegalovirus disease: report from the National Vaccine Advisory Committee. Clin. Infect. Dis. 39:233-239. http://dx.doi.org/10.1086/421999.
6. Prober CG, Enright AM. 2003. Congenital cytomegalovirus (CMV) infections: hats off to Alabama. J. Pediatr. 143:4-6. http://dx.doi.org/10.1016/S0022-3476(03)00290-7.
7. Yow MD, Demmler GJ. 1992. Congenital cytomegalovirus disease-20 years is long enough. N. Engl. J. Med. 326:702-703. http://dx.doi.org/10.1056/NEJM199203053261010.
8. Institute of Medicine Committee to Study Priorities for Vaccine Development. Vaccines for the 21st century: a tool for decision making. National Academy Press, Washington DC.
9. Sung H, Schleiss MR. 2010. Update on the current status of cytomegalovirus vaccines. Expert Rev. Vaccines 9:1303-1314. http://dx.doi.org/10.1586/erv.10.125.
10. Emery VC, Milne RSB. 2011. Recent developments in antiviral drugs for cytomegalovirus. Future Virol. 6:633-651. http://dx.doi.org/10.2217/fvl.11.30.
11. Picone O, Vauloup-Fellous C, Cordier AG, Du Chatelet IP, Senat MV, Frydman R, Grangeot-Keros L. 2009. A 2-year study on cytomegalovirus infection during pregnancy in a French hospital. BJOG 116:818-823. http://dx.doi.org/10.1111/j.1471-0528.2009.02139.x.
12. Vauloup-Fellous C, Piconec O, Cordier A-G, Parent-du-Chatelet I, Senat M-V, Frydman R, Grangeot-Keros L. 2009. Does hygiene counseling have an impact on the rate of CMV primary infection during pregnancy? Results of a 3-year prospective study in a French hospital. J. Clin. Virol. 46(Suppl 4):S49 -S53. http://dx.doi.org/10.1016/j.jcv.2009.09.003.
13. Adler SP. 1996. Current prospects for immunization against cytomegaloviral disease. Infect. Agents Dis. 5:29-35.
14. Cannon MJ, Pellett PE. 2005. Risk of congenital cytomegalovirus infection. Clin. Infect. Dis. 40:1701-1702. http://dx.doi.org/10.1086/430172.
15. Adler SP, Finney JW, Manganello AM, Best AM. 1996. Prevention of child-to-mother transmission of cytomegalovirus by changing behaviors: a randomized controlled trial. Pediatr. Infect. Dis. 15:240-246. http://dx.doi.org/10.1097/00006454-199603000-00013.
16. American Academy of Pediatrics. 2012. Cytomegalovirus infection, p 300-305. In Pickering LK, Kimberlin DW, Long SS (ed), Red book 2012: report of the Committee on Infectious Diseases. American Academy of Pediatrics, Elk Grove Village, IL.
17. Boppana SB, Fowler KB, Pass RF, Rivera LB, Bradford RD, Lakeman FD, Britt WJ. 2005. Congenital cytomegalovirus infection: association between virus burden in infancy and hearing loss. J. Pediatr. 146:817-823. http://dx.doi.org/10.1016/j.jpeds.2005.01.059.
18. Cannon MJ, Hyde TB, Schmid DS. 2011. Review of cytomegalovirus shedding in bodily fluids and relevance to congenital cytomegalovirus infection. Rev. Med. Virol. 21:240-255. http://dx.doi.org/10.1002/rmv.695.
19. Murph JR, Bale JF, Murray JC, Stinski MF, Perlman S. 1986. Cytomegalovirus transmission in a Midwest day-care center: possible relationship to child-care practices. J. Pediatr. 109:35-39. http://dx.doi.org/10.1016/S0022-3476(86)80568-6.
20. Hutto C, Little EA, Ricks R, Lee JD, Pass RF. 1986. Isolation of cytomegalovirus from toys and hands in a day-care center. J. Infect. Dis. 154: 527-530. http://dx.doi.org/10.1093/infdis/154.3.527.
21. Faix RG. 1987. Comparative efficacy of handwashing agents against cytomegalovirus. Infect. Control 8:158-162.
22. Stowell JD, Forlin-Passoni D, Din E, Radford K, Brown D, White A, Bate SL, Dollard SC, Bialek SR, Cannon MJ, Schmid DS. 2012. Cytomegalovirus survival on common environmental surfaces: opportunities for viral transmission. J. Infect. Dis. 205:211-214. http://dx.doi.org/10.1093/infdis/jir722.
23. Chan A, Mauro T. 2011. Acidification in the epidermis and the role of secretory phospholipases. Dermatoendocrinol. 3:84-90. http://dx.doi.org/10.4161/derm.3.2.15140.
24. Cohen J, Straus S, Arvin A. 2007. Varicella-zoster virus replication, pathogenesis and management, p 2773-2818. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
25. Fendler EJ, Ali Y, Hammond BS, Lyons MK, Kelley MB, Vowell NA. 2002, The impact of alcohol hand sanitizer use on infection rates in an extended care facility. Am. J. Infect. Control 30:226-233. http://dx.doi.org/10.1067/mic.2002.120129.
26. Nicas M, Jones RM. 2009. Relative contributions of four exposure pathways to influenza infection risk. Risk Analysis 29:1292-1303. http://dx.doi.org/10.1111/j.1539-6924.2009.01253.x.
27. Grayson ML, Melvani S, Druce J, Barr IG, Ballard SA, Johnson PDR, Mastorakos T, Birch C. 2009. Efficacy of soap and water and alcoholbased hand-rub preparations against live H1N1 influenza virus on the hands of human volunteers. Clin. Infect. Dis. 48:285-291. http://dx.doi.org/10.1086/595845.
28. Bellamy K, Alcock R, Babb JR, Davies JG, Ayliffe GAJ. 1993. A test for the assessment of hygienic hand disinfection using rotavirus. J. Hosp. Infect. 24:201-210. http://dx.doi.org/10.1016/0195-6701(93)90049-6.